E-LIB Suche - Ergebnisse für: Niesvizky, Ruben

1

Absolute Lymphocyte Count after BCMA CAR-T Therapy is a Pre..:

Mejia Saldarriaga, Mateo ; Pan, Darren ; Unkenholz, Caitlin...
Blood Advances. , 2024

2

P-358 Myeloma at a younger age presents with distinctive cl..:

Saldarriaga, Mateo Mejia ; Sowa, Aubrie ; Contreras, Jorge...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S236-S237 , 2023

Link: https://doi.org/10.1016/..

3

Publisher Correction: A pipeline for malignancy and therapy..:

Kimmerling, Robert J. ; Stevens, Mark M. ; Olcum, Selim...
Communications Biology. 6 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

4

POSTER: MM-374 Efficacy and Safety of Elranatamab in Patien..:

Nooka, Ajay K. ; Lesokhin, Alexander M. ; Mohty, Mohamad...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S219 , 2023

Link: https://doi.org/10.1016/..

5

OA-41 Iberdomide, bortezomib, and dexamethasone (IberVd) in..:

White, Darrell ; Lipe, Brea ; Mesa, Mercedes Gironella...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S25 , 2023

Link: https://doi.org/10.1016/..

6

P-359 Non-paraskeletal extramedullary disease is associated..:

Saldarriaga, Mateo Mejia ; Unkenholz, Caitlin ; Jayabalan, David...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S237 , 2023

Link: https://doi.org/10.1016/..

7

CD38 antibody re-treatment in daratumumab-refractory multip..:

Perez de Acha, Olivia ; Reiman, Lauren ; Jayabalan, David S....
Blood Advances. 7 (2023) 21 - p. 6430-6440 , 2023

Link: https://doi.org/10.1182/..

8

Elranatamab in relapsed or refractory multiple myeloma: pha..:

Lesokhin, Alexander M. ; Tomasson, Michael H. ; Arnulf, Bertrand...
Nature Medicine. 29 (2023) 9 - p. 2259-2267 , 2023

Link: https://doi.org/10.1038/..

9

Angioimmunoblastic T‐cell lymphoma presenting with severe p..:

Mejia Saldarriaga, Mateo ; Alhomoud, Mohammad ; Roboz, Gail...
American Journal of Hematology. 98 (2023) 7 - p. 1119-1126 , 2023

Link: https://doi.org/10.1002/..

10

P870: EFFICACY AND SAFETY OF ELRANATAMAB IN PATIENTS WITH R..:

Manier, Salomon ; Lesokhin, Alexander ; Mohty, Mohamad...
HemaSphere. 7 (2023) S3 - p. e26808c7 , 2023

Link: https://doi.org/10.1097/..

11

MM-364 Elranatamab, a B-Cell Maturation Antigen (BCMA)-CD3 ..:

Mohty, Mohamad ; Tomasson, Michael H. ; Arnulf, Bertrand...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S493-S494 , 2023

Link: https://doi.org/10.1016/..

12

MM-374 Efficacy and Safety of Elranatamab in Patients With ..:

Nooka, Ajay K. ; Lesokhin, Alexander M. ; Mohty, Mohamad...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S496-S497 , 2023

Link: https://doi.org/10.1016/..

13

POSTER: MM-364 Elranatamab, a B-Cell Maturation Antigen (BC..:

Mohty, Mohamad ; Tomasson, Michael H. ; Arnulf, Bertrand...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S225 , 2023

Link: https://doi.org/10.1016/..

14

P-320 Iberdomide (IBER) plus dexamethasone (DEX) in patient..:

van de Donk, Niels ; White, Darrell ; Lipe, Brea...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S214-S215 , 2023

Link: https://doi.org/10.1016/..

15

P-033: Patient multiple myeloma cells do not express target..:

Reiman, Lauren ; de Acha, Olivia Perez ; Jayabalan, David...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S53-S54 , 2022

Link: https://doi.org/10.1016/..